Page last updated: 2024-11-04

n-carbamoyl-beta-alanine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-carbamoyl-beta-alanine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

N-carbamoyl-beta-alanine : A beta-alanine derivative that is propionic acid bearing a ureido group at position 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID111
CHEMBL ID20962
CHEBI ID18261
SCHEMBL ID440563
MeSH IDM0107820

Synonyms (67)

Synonym
STL353338
3-(carbamoylamino)propanoic acid
3-ureidopropionic acid
ureidopropanoic acid
n-(aminocarbonyl)-beta-alanine
ureidopropionic acid
3-[(aminocarbonyl)amino]propanoic acid
3-ureidopropanoic acid
CHEBI:18261 ,
URP ,
ureidopropionate
3-(carbamoylamino)propanoate
nsc65768
nsc-65768
UPCMLD00WMAL376
OPREA1_716618
3-UREIDO-PROPIONATE ,
C02642
beta-ureidopropionic acid
462-88-4
3-ureidopropanoate
n-carbamoyl-beta-alanine
3-ureidopropionate
3-ureidopropionic acid, >=98.0% (t)
F5C2CDE7-4DD6-42C0-9111-B868B847F389
propanoic acid, 3-ureido-
CHEMBL20962
3-ureido-propionic acid
AKOS000264530
beta-alanine, n-(aminocarbonyl)-
BMSE000333
L001020
BMSE000641
c24ql9bq36 ,
unii-c24ql9bq36
nsc 65768
EN300-10729
FT-0675740
S6143
SCHEMBL440563
AB01329255-02
.beta.-alanine, n-(aminocarbonyl)-
n-carbamoyl-.beta.-alanine
DTXSID60196771
AS-57811
carbamoyl-beta-ala-oh
mfcd00043023
beta-ureidopropionate
n-(aminocarbonyl)-b-alanine
n-carbamyl-beta-alanine
carbamoyl-b-ala-oh
n-carbamyl-b-alanine
n-carbamoyl-b-alanine
n-(aminocarbonyl)-'b-alanine
HY-113285
CS-0059512
carbamoyl--ala-oh
n-carbamyl-beta-alanine; beta-ureidopropionate
carbamoyl-|a-ala-oh
Q3008585
carbamoyl-b-alanine
NCGC00337701-01
propanoic acid, 3-((aminocarbonyl)amino)-
carbamoyl-.beta.-alanine
n-(aminocarbonyl)-.beta.-alanine
n-carbamoyl-
Z56347556
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
beta-alanine derivative
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (12)

PathwayProteinsCompounds
Pyrimidine Metabolism2353
beta-Alanine Metabolism927
GABA-Transaminase Deficiency927
beta-Ureidopropionase Deficiency2353
UMP Synthase Deficiency (Orotic Aciduria)2353
Dihydropyrimidinase Deficiency2353
MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)2353
Ureidopropionase Deficiency927
Carnosinuria, Carnosinemia927
Pyrimidine Nucleotides and Nucleosides metabolism ( Pyrimidine Nucleotides and Nucleosides metabolism )4549
5,6-Dihydro-uracil + H2O = Ureido-propanoic acid ( Pyrimidine Nucleotides and Nucleosides metabolism )13
Biochemical pathways: part I0466
Pyrimidine metabolism038

Bioassays (1)

Assay IDTitleYearJournalArticle
AID94678In vivo blood glucose was determined in obese, hyperglycemic, hyperinsulinemic, insulin-resistant KKAy mice after a dose of 500 mg/kg for 4 days2001Journal of medicinal chemistry, Apr-12, Volume: 44, Issue:8
Synthesis and biological activity of analogues of the antidiabetic/antiobesity agent 3-guanidinopropionic acid: discovery of a novel aminoguanidinoacetic acid antidiabetic agent.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (36.36)18.7374
1990's4 (18.18)18.2507
2000's7 (31.82)29.6817
2010's3 (13.64)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.85 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.40 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.55%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (9.09%)4.05%
Observational0 (0.00%)0.25%
Other19 (86.36%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]